See also this year's filing and all EDGAR filings for this company.
PDF Report 0000316253_2017_ENZO_Biochem_INC.pdf
Logs
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.008121497604158206, 'aggregate_val': 24826000, 'exp_sum': 24626000, 'exp_to_value': {'LongTermLiabilities': 774000, 'LiabilitiesCurrent': 23852000, 'remainder_Liabilities': 0}} |
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.006708702984089742, 'aggregate_val': 27461000, 'exp_sum': 27278000, 'exp_to_value': {'LongTermLiabilities': 2313000, 'LiabilitiesCurrent': 24965000, 'remainder_Liabilities': 0}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000316253, ENZO Biochem INC
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 11,874,000 |
1 | AssetsNonCurrent | 336,000 |
2 | AssetsCurrent | 91,397,000 |
3 | PropertyPlantAndEquipment | 8,214,000 |
4 | remainder_Assets | 0 |
5 | LongTermLiabilities | 1,699,000 |
6 | LiabilitiesCurrent | 20,568,000 |
7 | remainder_Liabilities | 0 |
8 | LaborExpense | 0 |
9 | CostOfGoodsAndServicesSold | 0 |
10 | GeneralAndAdministrativeExpense | 43,586,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 0 |
13 | DepreciationDepletionAndAmortization | 0 |
14 | SellingAndMarketingExpense | 0 |
15 | ResearchAndDevelopmentExpense | 3,524,000 |
16 | remainder_Expenses | 9,889,000 |
17 | remainder_Revenues | 102,773,000 |
18 | remainder_NetIncome | -488,000 |
19 | remainder_ComprehensiveNetIncome | 338,000 |
yvar | yval | |
---|---|---|
0 | Assets | 111,821,000 |
1 | Liabilities | 22,267,000 |
2 | Expenses | 56,999,000 |
3 | Revenues | 102,773,000 |
4 | StockholdersEquity | 89,554,000 |
5 | NetIncome | 45,286,000 |
6 | ComprehensiveNetIncome | 45,624,000 |
7 | BaseVar | 147,343,000 |
8 | EconomicCapitalRatio | 4.39 |